Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
memo - Magazine of European Medical Oncology
Published in: memo - Magazine of European Medical Oncology 3/2023

01-09-2023 | Pediatrics | editorial

Long-term survival and follow-up care after cancer in Austria

Author: PD Dr. Alexandra Böhm

Published in: memo - Magazine of European Medical Oncology | Issue 3/2023

Login to get access

Excerpt

This edition of Magazine of European Medical Oncology (MEMO) focuses on long-term oncological follow-up care in Austria with an article about oncological rehabilitation and an article about the care of young adults after successfully treated cancer in childhood and adolescence. …
Literature
1.
Bardi E, Karger L, Holter W. How the long term follow up is organized in young adult survivors of childhood cancer. memo. 2023;16(2).
2.
Hassler M. Late complications after oncological therapy. Cancer survivorship and oncological rehabilitation. memo. 2023;16(2).
Metadata
Title
Long-term survival and follow-up care after cancer in Austria
Author
PD Dr. Alexandra Böhm
Publication date
01-09-2023
Publisher
Springer Vienna
Keywords
Pediatrics
Care
Published in
memo - Magazine of European Medical Oncology / Issue 3/2023
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-023-00895-0

Other articles of this Issue 3/2023

memo - Magazine of European Medical Oncology 3/2023 Go to the issue

short review

New developments in radiation oncology for head and neck cancers

short review

ASH highlights 2022—multiple myeloma

short review

Aggressive B cell lymphomas—highlights from ASH 2022

short review

Lipid nanoparticles in the treatment of lung cancer—hype or hope?

editorial

American Society of Hematology meeting update

review

ASH 2022—new developments in acute myeloid leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits